*Manufacturers of 10 Drugs Slated for Medicare Price Negotiation Spent Billions More on Buybacks, Dividends and Executive Compensation than R&D.*

US drug companies have worked hard to corrupt the system of studies to measure the effects of approved and proposed medicines. They can do this because the investigations get their funds from the drug companies. Therefore, we should take those studies entirely away from companies. The government should pay for these studies, getting funds from drug companies through taxes but denying them any say about what will be tested or by whom.